Search Results - "LAGARDE, Sjoerd M"

A Propensity Score Matched Analysis of Open Versus Minimally Invasive Transthoracic Esophagectomy in the Netherlands by Seesing, Maarten F J, Gisbertz, Suzanne S, Goense, Lucas, van Hillegersberg, Richard, Kroon, Hidde M, Lagarde, Sjoerd M, Ruurda, Jelle P, Slaman, Annelijn E, van Berge Henegouwen, Mark I, Wijnhoven, Bas P L

“…OBJECTIVE:The aim of this study was to compare open esophagectomy (OE) with minimally invasive esophagectomy (MIE) in a population-based setting…”
Get full text

Characteristics Predicting Short-Term and Long-Term Health-Related Quality of Life in Patients with Esophageal Cancer After Neoadjuvant Chemoradiotherapy and Esophagectomy by van der Wilk, Berend J., Eyck, Ben M., Noordman, Bo J., Kranenburg, Leonieke W., Oppe, Mark, Lagarde, Sjoerd M., Wijnhoven, Bas P. L., Busschbach, Jan J., van Lanschot, J. Jan B.

“…Background Esophagectomy is associated with lasting effect on health-related quality of life (HRQOL). Patients desire detailed information on the expected…”
Get full text

Towards an Organ-Sparing Approach for Locally Advanced Esophageal Cancer by van der Wilk, Berend Jan, Eyck, Ben M, Spaander, Manon C W, Valkema, Roelf, Lagarde, Sjoerd M, Wijnhoven, Bas P L, van Lanschot, J Jan B

“…Active surveillance after neoadjuvant therapies has emerged among several malignancies. During active surveillance, frequent assessments are performed to…”
Get more information

Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): a prospective multicenter diagnostic cohort study by Zhang, Xiaobin, Eyck, Ben M, Yang, Yang, Liu, Jun, Chao, Yin-Kai, Hou, Ming-Mo, Hung, Tsung-Min, Pang, Qingsong, Yu, Zhen-Tao, Jiang, Hongjing, Law, Simon, Wong, Ian, Lam, Ka-On, van der Wilk, Berend J, van der Gaast, Ate, Spaander, Manon C W, Valkema, Roelf, Lagarde, Sjoerd M, Wijnhoven, Bas P L, van Lanschot, J Jan B, Li, Zhigang

“…After neoadjuvant chemoradiotherapy (nCRT) for esophageal cancer, high pathologically complete response (pCR) rates are being achieved especially in patients…”
Get full text

A systematic review and meta-analysis of prognostic biomarkers in resectable esophageal adenocarcinomas by Creemers, Aafke, Ebbing, Eva A., Pelgrim, Thomas C., Lagarde, Sjoerd M., van Etten-Jamaludin, Faridi S., van Berge Henegouwen, Mark I., Hulshof, Maarten C. C. M., Krishnadath, Kausilia K., Meijer, Sybren L., Bijlsma, Maarten F., van Oijen, Martijn G. H., van Laarhoven, Hanneke W. M.

“…Targeted therapy is lagging behind in esophageal adenocarcinoma (EAC). To guide the development of new treatment strategies, we provide an overview of the…”
Get full text

Postoperative Complications After Esophagectomy for Adenocarcinoma of the Esophagus Are Related to Timing of Death Due to Recurrence by LAGARDE, Sjoerd M, DE BOER, Johannes D, TEN KATE, Fiebo J. W, BUSCH, Olivier R. C, OBERTOP, Huug, VAN LANSCHOT, Jan J. B

“…Esophagectomy is frequently accompanied by substantial complications with secondary disturbance of the immune system. After esophagectomy for adenocarcinoma of…”
Get full text

The influence of prophylactic proton pump inhibitor treatment on the development of symptomatic marginal ulceration in Roux-en-Y gastric bypass patients: a historic cohort study by Coblijn, Usha K., M.D, Lagarde, Sjoerd M., M.D., Ph.D, de Castro, Steve M.M., M.D., Ph.D, Kuiken, Sjoerd D., M.D., Ph.D, van Tets, Willem F., M.D., Ph.D, van Wagensveld, Bart A., M.D., Ph.D

“…Abstract Background Marginal ulceration at the gastrojejunostomy is a serious complication after laparoscopic Roux-en-Y gastric bypass surgery (LRYGB) and…”
Get full text

Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features by Buskens, Christianne J., Westerterp, Marinke, Lagarde, Sjoerd M., Bergman, Jacques J.G.H.M., ten Kate, Fiebo J.W., van Lanschot, J. Jan B.

“…Endoscopic techniques are being developed for the local treatment of early stage esophageal cancer. However, such therapy is not appropriate for patients with…”
Get full text

Prognostic Factors in Adenocarcinoma of the Esophagus or Gastroesophageal Junction by LAGARDE, Sjoerd M, TEN KATE, Fiebo J. W, REITSMA, Johannes B, BUSCH, Olivier R. C, VAN LANSCHOT, J. Jan B

“…The incidence of adenocarcinoma of the esophagus is rising rapidly in Western Europe and North America. It is an aggressive disease with early lymphatic and…”
Get full text

A population-based study in resected esophageal or gastroesophageal junction cancer aligned with CheckMate 577 by Pape, Marieke, Vissers, Pauline A.J., Beerepoot, Laurens V., van Berge Henegouwen, Mark I., Lagarde, Sjoerd M., Mook, Stella, Moehler, Markus, van Laarhoven, Hanneke W.M., Verhoeven, Rob H.A.

“…Background: Results of CheckMate 577 show an improved disease-free survival for patients with resected esophageal or gastroesophageal junction cancer treated…”
Get full text

Evidence-Based Surgical Treatment of Esophageal Cancer: Overview of High-Quality Studies by Lagarde, Sjoerd M., MD, PhD, Vrouenraets, Bart C., MD, PhD, Stassen, Laurents P.S., MD, PhD, van Lanschot, J. Jan B., MD, PhD

“…Evidence-based medicine is the conscientious, explicit, and judicious use of best available evidence in making decisions for individual patient care. The…”
Get full text

ChemoTherapy aNd chemoradioTherapy for adenocarcinoma of the OESophagus and esophagogastric junction with oligometastases: Protocol of the TNT-OES-1 trial by van der Zijden, Charlène J., Eyck, Ben M., van der Gaast, Ate, van Doorn, Leni, Nuyttens, Joost J.M.E., van Lanschot, J. Jan B., Wijnhoven, Bas P.L., Mostert, Bianca, Lagarde, Sjoerd M.

“…FLOT and CROSS are effective neoadjuvant regimens for esophageal cancer patients. Chemotherapy (FLOT) is aimed to have merely a systemic effect whereas…”
Get full text

The effectiveness of neoadjuvant chemoradiotherapy in oesophageal adenocarcinoma with presence of extracellular mucin, signet‐ring cells, and/or poorly cohesive cells by Valkema, Maria J, Vos, Anne‐Marie, Post, Rachel S, Ooms, Ariadne HAG, Oudijk, Lindsey, Eyck, Ben M, Lagarde, Sjoerd M, Wijnhoven, Bas PL, Klarenbeek, Bastiaan R, Rosman, Camiel, Lanschot, J Jan B, Doukas, Michail

“…Oesophageal adenocarcinomas may show different histopathological patterns, including excessive acellular mucin pools, signet‐ring cells (SRCs), and poorly…”
Get full text

Validation of a Nomogram Predicting Complications After Esophagectomy for Cancer by Grotenhuis, Brechtje A., MD, van Hagen, Pieter, MD, Reitsma, Johannes B., MD, PhD, Lagarde, Sjoerd M., MD, PhD, Wijnhoven, Bas P.L., MD, PhD, van Berge Henegouwen, Mark I., MD, PhD, Tilanus, Hugo W., MD, PhD, van Lanschot, J. Jan B., MD, PhD

“…Background A nomogram has been developed recently in order to predict the occurrence and severity of postoperative complications after esophagectomy for…”
Get full text

Preoperative Prediction of the Occurrence and Severity of Complications After Esophagectomy for Cancer With Use of a Nomogram by Lagarde, Sjoerd M., MD, Reitsma, Johannes B., MD, Maris, Anna-Karin D., MS, van Berge Henegouwen, Mark I., MD, Busch, Olivier R.C., MD, Obertop, Hugo, MD, Zwinderman, Aelko H., AH, PhD, van Lanschot, J. Jan B., MD

“…Background Predicting the severity of complications after esophagectomy may supply important information for both patient and surgeon. The aim of the present…”
Get full text

Largely varying patterns and trends of primary cancer-directed resection for gastric carcinoma with synchronous distant metastasis in Europe and the US: a population-based study calling for further standardization of care by Huang, Lei, Jansen, Lina, Verhoeven, Rob H.A., Ruurda, Jelle P., Van Eycken, Liesbet, De Schutter, Harlinde, Johansson, Jan, Lindblad, Mats, Johannesen, Tom B., Zadnik, Vesna, Žagar, Tina, Mägi, Margit, Lagarde, Sjoerd M., Bastiaannet, Esther, van de Velde, Cornelis J.H., Schrotz-King, Petra, Brenner, Hermann

“…Aims: The role of resection remains debated in cases of metastatic gastric carcinoma (mGC). Some mGCs are technically resectable. At the population level, the…”
Get full text

Evaluation of the obesity surgery mortality risk score for the prediction of postoperative complications after primary and revisional laparoscopic Roux-en-Y gastric bypass by Coblijn, Usha K., M.D, Lagarde, Sjoerd M., M.D., Ph.D, de Raaff, Christel A.L., M.D, de Castro, Steve M., M.D., Ph.D, van Tets, Willem F., M.D., Ph.D, Jaap Bonjer, H., M.D., Ph.D, van Wagensveld, Bart A., M.D., Ph.D

“…Abstract Background The Obesity Surgery Mortality Risk Score (OS-MRS) is a validated instrument for mortality risk prediction in patients undergoing…”
Get full text

Survival trends of patients with non‐metastatic gastric adenocarcinoma in the US and European countries: the impact of decreasing resection rates by Huang, Lei, Jansen, Lina, Verhoeven, Rob H.A., Ruurda, Jelle P., Van Eycken, Liesbet, De Schutter, Harlinde, Johansson, Jan, Lindblad, Mats, Johannesen, Tom B., Zadnik, Vesna, Žagar, Tina, Lagarde, Sjoerd M., Velde, Cornelis J.H., Schrotz‐King, Petra, Brenner, Hermann

“…Background We previously observed decreasing resection rates of non‐metastatic gastric adenocarcinoma (GaC) in the US and some European countries. If and to…”
Get full text

Developing an e‐learning tool for clinicians to take patient preferences into account in esophageal cancer treatment decision‐making by Hermus, Merel, Wilk, Berend J., Dekker, Jan Willem T., Nieuwenhuijzen, Grard A. P., Rosman, Camiel, Timmermans, Liesbeth, Wijnhoven, Bas P. L., Zijden, Charlène J., Lanschot, J. Jan B., Busschbach, Jan J., Lagarde, Sjoerd M., Kranenburg, Leonieke W.

“…INTRODUCTION Shared decision-making (SDM) has gained much attention in health care policy. 1–3 SDM is especially recommended when patients face…”
Get full text

Decreasing resection rates for nonmetastatic gastric cancer in Europe and the United States by Huang, Lei, Jansen, Lina, Balavarca, Yesilda, Verhoeven, Rob H.A., Ruurda, Jelle P., Van Eycken, Liesbet, De Schutter, Harlinde, Johansson, Jan, Lindblad, Mats, Johannesen, Tom B., Zadnik, Vesna, Žagar, Tina, Mägi, Margit, Bastiaannet, Esther, Lagarde, Sjoerd M., van de Velde, Cornelis J.H., Schrotz‐King, Petra, Brenner, Hermann

“…Background Resection is the cornerstone of curative treatment for many nonmetastatic gastric cancers (GCs), but the population treatment patterns remains…”
Get full text